Granberg D - Search Results

1

Prospective observational study of ¹⁷⁷Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity.

Garske-Román U, Sandström M, Fröss Baron K, Lundin L, Hellman P, Welin S, Johansson S, Khan T, Lundqvist H, Eriksson B, Sundin A, Granberg D. Garske-Román U, et al. Among authors: granberg d. Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):970-988. doi: 10.1007/s00259-018-3945-z. Epub 2018 Mar 1. Eur J Nucl Med Mol Imaging. 2018. PMID: 29497803 Free PMC article.

2

Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I.

Skogseid B, Oberg K, Eriksson B, Juhlin C, Granberg D, Akerström G, Rastad J. Skogseid B, et al. Among authors: granberg d. World J Surg. 1996 Sep;20(7):872-6; discussion 877. doi: 10.1007/s002689900133. World J Surg. 1996. PMID: 8678965

3

Plasma chromogranin A in patients with multiple endocrine neoplasia type 1.

Granberg D, Stridsberg M, Seensalu R, Eriksson B, Lundqvist G, Oberg K, Skogseid B. Granberg D, et al. J Clin Endocrinol Metab. 1999 Aug;84(8):2712-7. doi: 10.1210/jcem.84.8.5938. J Clin Endocrinol Metab. 1999. PMID: 10443665

4

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors.

Fjällskog ML, Granberg DP, Welin SL, Eriksson C, Oberg KE, Janson ET, Eriksson BK. Fjällskog ML, et al. Among authors: granberg dp. Cancer. 2001 Sep 1;92(5):1101-7. doi: 10.1002/1097-0142(20010901)92:5<1101::aid-cncr1426>3.0.co;2-v. Cancer. 2001. PMID: 11571721 Clinical Trial.

5

Experience in treatment of metastatic pulmonary carcinoid tumors.

Granberg D, Eriksson B, Wilander E, Grimfjärd P, Fjällskog ML, Oberg K, Skogseid B. Granberg D, et al. Ann Oncol. 2001 Oct;12(10):1383-91. doi: 10.1023/a:1012569909313. Ann Oncol. 2001. PMID: 11762808 Free article.

6

In situ RNA-RNA hybridisation of phospholipase C beta 3 shows lack of expression in neuroendocrine tumours.

Stålberg P, Granberg D, Carling T, Wilander E, Eriksson B, Gobl A, Akerström G, Rastad J, Modlin IM, Oberg K, Skogseid B. Stålberg P, et al. Among authors: granberg d. Anticancer Res. 2003 May-Jun;23(3B):2227-32. Anticancer Res. 2003. PMID: 12894496

7

Octreoscan in patients with bronchial carcinoid tumours.

Granberg D, Sundin A, Janson ET, Oberg K, Skogseid B, Westlin JE. Granberg D, et al. Clin Endocrinol (Oxf). 2003 Dec;59(6):793-9. doi: 10.1046/j.1365-2265.2003.01931.x. Clin Endocrinol (Oxf). 2003. PMID: 14974924

8

High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours.

Welin SV, Janson ET, Sundin A, Stridsberg M, Lavenius E, Granberg D, Skogseid B, Oberg KE, Eriksson BK. Welin SV, et al. Among authors: granberg d. Eur J Endocrinol. 2004 Jul;151(1):107-12. doi: 10.1530/eje.0.1510107. Eur J Endocrinol. 2004. PMID: 15248829 Clinical Trial.

9

Neuroendocrine tumours.

Granberg D, Oberg K. Granberg D, et al. Cancer Chemother Biol Response Modif. 2005;22:471-83. Cancer Chemother Biol Response Modif. 2005. PMID: 16110625 Review. No abstract available.

10

Gastrin-releasing-peptide in neuroendorine tumours.

Granberg D, Skogseid B, Welin S, Orlefors H, Oberg K, Wilander E. Granberg D, et al. Acta Oncol. 2006;45(1):23-7. doi: 10.1080/02841860500367434. Acta Oncol. 2006. PMID: 16464792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page